Replies to post #21755 on Intellipharmaceutics International Inc. (IPCI)

[Tekterra]

One step at a time I guess, now we wait for acceptance. Then the FDA advisory committee review. One thing for sure is that the abuse deterrent label is very important as we can see with EGLT's recent development. It sets Rexista apart from what's already out in the market. That's what makes it valuable.

You guys were expecting a 6 month approval, but in reality other companies before ICPI have had and overall approval time of about one year. Let just hope Trump and new FDA funding will speed things up more so we don't have to wait till year end for approval. Critical times for IPCI in 2017. Cross fingers management pull us through partnership and approval.

[AngeloFoca]

I personally don't see that happening

Neither do I.

I'm in fact HOPING the acceptance will come early... like mid next week... perhaps.